Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile

Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
70 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Biocept, Inc. (Biocept) is a medical equipment company that provides diagnostics services. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers OncoCEE technology, related instrumentation and analytical capabilities for rare event detection and genetic characterization. The companys OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood.

Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, de

  
Source:
Document ID
GDME5968D
Country
Industry
Ticker
BIOC=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Biocept, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201652
Biocept, Inc., Medical Equipment Deals By Type, 2010 to YTD 201671
Biocept, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201681
Biocept, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201691
Biocept, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016101
Biocept, Inc., Medical Equipment, Deal Details1122
  Venture Financing111
    Biocept Raises Funds In Growth Equity Financing Round111
    Biocept Raises US$2.3 Million In Venture Financing121
    Biocept Raises US$3.6 Million In Financing Round131
  Partnerships141
    Biocept Enters into Agreement with Teneovita Medical Innovations141
    Biocept Forms Partnership with MedStar Georgetown University Hospital151
    Biocept to Form Partnership with Quest Diagnostics Mexico161
    Biocept Enters into Agreement171
    Biocept Enters into Distribution Agreement with Progenetics181
    Biocept Enters into Co-Development Agreement with Baylor College of Medicine191
    Biocept Enters into Partnership with Life Technologies201
    Biocept Enters Into Co-Marketing Agreement With Clarient211
  Equity Offering221
    Biocept Prices Public Offering of Shares and Warrants for USD10 Million222
    Biocept Prices Public Offering of Shares and Warrants for USD5 Million242
    Biocept to Raise USD15 Million in Public Offering of Shares262
    Biocept Prices Public Offering of Shares and Warrants for USD10 Million282
    Biocept Completes IPO For US$19 Million302
    Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock321
Biocept, Inc. - Key Competitors331
Key Employees341
Locations And Subsidiaries351
  Head Office351
Recent Developments361
Strategy And Business Planning361
Sep 28, 2015: Biocept Announces Participation in MultiPlan s Networks361
Sep 14, 2015: Biocept Secures Agreements with Preferred Provider Organizations Stratose and Galaxy Health Network for its Proprietary Blood-Based Oncology Diagnostic Assays371
Aug 11, 2015: Biocept and University of California, Irvine to Study Blood-based Liquid Biopsy Testing in Cancer Patients381
Financial Announcements391
Aug 02, 2016: Biocept Reports 2016 Second Quarter Financial Results392
May 12, 2016: Biocept Reports 2016 First Quarter Financial Results411
Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results422
Nov 05, 2015: Biocept Reports Third Quarter 2015 Financial Results443
Aug 10, 2015: Biocept Reports Second Quarter 2015 Financial Results472
May 12, 2015: Biocept Reports First Quarter 2015 Financial Results492
Mar 09, 2015: Biocept Reports Fourth Quarter 2014 Financial Results512
Corporate Communications531
Jul 27, 2016: Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations532
Aug 21, 2015: Biocept Announces Personnel Change551
Aug 03, 2015: Dr. Marileila Varella Garcia Joins Biocept as Scientific Advisor561
Mar 05, 2015: Next Generation Sequencing Veteran Joins Biocept571
Mar 02, 2015: Dr. David Rimm Joins Biocept as a Scientific Advisor581
Product News591
Feb 26, 2016: Data Demonstrating Extremely High Sensitivity of Biocept's Blood-Based Liquid Biopsy in Detecting Lung Cancer Mutations Presented at UCSD Moores Cancer Center Translational Oncology Symposium591
Sep 08, 2015: Biocept's Liquid Biopsy Lung Cancer Target Selector Assay to be featured at World Conference on Lung Cancer601
Mar 10, 2015: Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities for EGFR Mutations611
Other Significant Developments621
Sep 09, 2016: Biocept to Collaborate with Renowned Clinical Investigator Dr. Shilpa Gupta to Study the Utility of Liquid Biopsy Testing in Bladder and Prostate Cancers621
Aug 11, 2016: Biocept Expands Distribution of Liquid Biopsy Tests to the Philippines631
May 23, 2016: Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests641
Mar 23, 2016: Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award651
Mar 10, 2016: Progenetics to Distribute Biocept's Liquid Biopsy Assays in Israel661
Feb 29, 2016: Biocept Secures Agreement with Preferred Provider Organization Prime Health Services671
Jan 12, 2016: Biocept Announces In-Network Agreement with Blue Cross Blue Shield of Illinois681
Nov 23, 2015: Biocept Secures Agreements with Preferred Provider Organizations Fortified Provider Network and Three Rivers Provider Network691
Appendix701
  Methodology701
  About GlobalData701
  Contact Us701
  Disclaimer701

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Biocept-Inc-BIOC-Medical-Equipment-Deals-and-Alliances-Profile-2148-11294>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Biocept-Inc-BIOC-Medical-Equipment-Deals-and-Alliances-Profile-2148-11294>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research